A93 POST-INDUCTION INFLIXIMAB TROUGH LEVELS VARY WIDELY AND AID IN INDIVIDUALIZING INFLIXIMAB MAINTENANCE THERAPY FOR PEDIATRIC IBD

BACKGROUND: Clinical trial data in patients with IBD shows that infliximab (IFX) efficacy correlates with trough drug levels. Absence of drug predisposes to antibody formation and secondary loss of response. AIMS: We aimed to individualize IFX regimens through early post-induction drug levels in ped...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Can Assoc Gastroenterol
Главные авторы: Popalis, C M, Frost, K, Carman, N J, Walters, T D, Griffiths, A, Church, P C
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Poster Presentations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507576/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.094
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы